Skip to main navigation

Skip to content

Search

Toggle search form
- Search for:
Follow us on Twitter
Connect with us on LinkedIn

Investor Relations

Our Team
Our Development Program
For Patients
Investors/Media
Join Us
Contact Us

Search for:

Press Releases

Q3 2022 Infinity Pharmaceuticals, Inc. Earnings Conference Call

Nov 14, 2022 at 8:30 AM EST

Listen to webcast

Keyword Search

Year:

Summary Toggle Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer Research

April 13, 2023 at 4:05 PM EDT
Summary Toggle Infinity Pharmaceuticals Reports Full Year 2022 Financial Results

March 28, 2023 at 4:05 PM EDT
Summary Toggle MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates

February 23, 2023 at 7:00 AM EST
Summary Toggle Infinity Pharmaceuticals to Participate in Piper Sandler 34th Annual Healthcare Conference

November 22, 2022 at 8:35 AM EST
Summary Toggle Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

November 14, 2022 at 7:07 AM EST
Summary Toggle Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of Eganelisib

November 14, 2022 at 7:05 AM EST
Summary Toggle Infinity Pharmaceuticals Announces the Date of Its Third Quarter 2022 Financial Results Conference Call and Webcast

November 7, 2022 at 8:25 AM EST
Summary Toggle Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences

August 31, 2022 at 7:00 AM EDT
Summary Toggle Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

August 9, 2022 at 4:05 PM EDT
Summary Toggle Infinity Pharmaceuticals Announces the Date of Its Second Quarter 2022 Financial Results Conference Call and Webcast

August 2, 2022 at 8:25 AM EDT

Pagination

Current page 1
Page 2
Page 3
Page 4
…
Next page
Last page

Shareholder Tools

RSS Feeds

RSS Feeds
Email Alerts

Email Alerts
Print

Print
Email

Email

Infinity Pharmaceuticals, Inc.

1100 Massachusetts Ave
Cambridge, MA 02138
617-453-1000

Terms and Conditions

Terms & Conditions
Privacy Policy
Forward Looking Statements

Connect With Us

Our Team

Our Team

Our Development Program

Our Development Program

Investor / Media

Investors/Media

Join Us

Join Us

© 2023 Infinity Pharmaceuticals, Inc. All Rights Reserved.